BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4147051)

  • 1. Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1973 Jul; 25(7):544-9. PubMed ID: 4147051
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol.
    Alkondon M; Ray A; Sen P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):161-7. PubMed ID: 2865935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antinociceptive activities of oxotremorine, physostigmine and dyflos.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1972 Jul; 24(7):547-51. PubMed ID: 4403848
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cholinesterase inhibitors on the susceptibility to pentetrazole of the mouse.
    György L; Döda M
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):243-51. PubMed ID: 4471270
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.
    Szerb JC; Somogyi GT
    Nat New Biol; 1973 Jan; 241(108):121-2. PubMed ID: 4512454
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction between some anticholinesterase drugs and atropine on the pentobarbital sleeping time in the rat.
    Kayaalp SO; Numanoğlu S
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):403-10. PubMed ID: 5868590
    [No Abstract]   [Full Text] [Related]  

  • 7. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice.
    Baratti CM; Huygens P; Miño J; Merlo A; Gardella J
    Psychopharmacology (Berl); 1979 Jun; 64(1):85-8. PubMed ID: 113837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1978 Jan; 27(2):203-11. PubMed ID: 623676
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected synergism between an alkylating analog of oxotremorine and soman.
    Jenden DJ; Overstreet DH; Booth RA; Russell RW; Rice KM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S78-83. PubMed ID: 4092897
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of oximes on the acute toxicity of anticholinesterase carbamates.
    Natoff IL; Reiff B
    Toxicol Appl Pharmacol; 1973 Aug; 25(4):569-75. PubMed ID: 4741778
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of DFP, atropine and pyridinium aldoximes on the rate of clearance of diisopropyl phosphate (DI32P) from the mouse circulatory system.
    Ramachandran BV
    Biochem Pharmacol; 1967 Nov; 16(11):2061-8. PubMed ID: 4229543
    [No Abstract]   [Full Text] [Related]  

  • 12. The potentiation by anticholinesterase drugs of the responses of the guinea-pig isolated vas deferens to alternate preganglionic and postganglionic stimulation.
    Birmingham AT
    Br J Pharmacol Chemother; 1966 May; 27(1):145-56. PubMed ID: 6006720
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of a single dose of an acetylcholinesterase inhibitor on oxotremorine- and nicotine-induced hypothermia in mice.
    Clement JG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):929-34. PubMed ID: 1763113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
    Pertwee RG; Ross TM
    Neuropharmacology; 1991 Jan; 30(1):67-71. PubMed ID: 1646420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tremorine-oxotremorine-induced tremor, hypothermia and analgesia, and physostigmine toxicity, in mice after pretreatment with beta-adrenoceptor antagonists.
    Barar FS; Madan BR
    J Pharm Pharmacol; 1976 Apr; 28(4):286-9. PubMed ID: 6716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation of the cholinergic system in temperature regulation by the mouse].
    Staib AH; Schröder M
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):88-95. PubMed ID: 5093196
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of atropine and dyflos on tremor and increase in whole brain acetylcholine produced by injection of oxotremorine in the rat.
    Cox B; Potkonjak D
    Br J Pharmacol; 1969 Mar; 35(3):521-9. PubMed ID: 5809741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse.
    Doggett NS; O'Farrell SA
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):149-55. PubMed ID: 1012335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective potentiation by naloxone of L-dopa but not atropine suppression of oxotremorine-induced tremor in mice.
    Quock RM; Lucas TS
    J Pharm Pharmacol; 1985 Sep; 37(9):673-4. PubMed ID: 2867196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
    Schmidt J; Wolf H
    Acta Biol Med Ger; 1972; 29(4):723-8. PubMed ID: 4653305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.